My Size, Inc.·4

Jul 17, 5:05 PM ET

Luzon Ronen 4

4 · My Size, Inc. · Filed Jul 17, 2023

Insider Transaction Report

Form 4
Period: 2023-07-13
Luzon Ronen
DirectorChief Executive Officer
Transactions
  • Award

    Option to purchase Common Stock (right to buy)

    2023-07-13+1,6011,601 total
    Exercise: $1.09Exp: 2024-05-29Common Stock, $.001 par value per share (1,601 underlying)
  • Disposition to Issuer

    Option to purchase Common Stock (right to buy)

    2023-07-136,4000 total
    Exercise: $26.00Exp: 2025-08-10Common Stock, $.001 par value per share (6,400 underlying)
  • Disposition to Issuer

    Option to purchase Common Stock (right to buy)

    2023-07-135,2000 total(indirect: See footnote)
    Exercise: $26.00Exp: 2025-08-10Common Stock, $.001 par value per share (5,200 underlying)
  • Disposition to Issuer

    Option to purchase Common Stock (right to buy)

    2023-07-138940 total(indirect: See footnote)
    Exercise: $26.00Exp: 2024-05-29Common Stock, $.001 par value per share (894 underlying)
  • Award

    Option to purchase Common Stock (right to buy)

    2023-07-13+5,2005,200 total(indirect: See footnote)
    Exercise: $1.09Exp: 2025-08-10Common Stock, $.001 par value per share (5,200 underlying)
  • Award

    Option to purchase Common Stock (right to buy)

    2023-07-13+894894 total(indirect: See footnote)
    Exercise: $1.09Exp: 2024-05-29Common Stock, $.001 par value per share (894 underlying)
  • Award

    Option to purchase Common Stock (right to buy)

    2023-07-13+6,4006,400 total
    Exercise: $1.09Exp: 2025-08-10Common Stock, $.001 par value per share (6,400 underlying)
  • Disposition to Issuer

    Option to purchase Common Stock (right to buy)

    2023-07-131,6010 total
    Exercise: $26.00Exp: 2024-05-29Common Stock, $.001 par value per share (1,601 underlying)
Footnotes (3)
  • [F1]Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.
  • [F2]Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged.
  • [F3]Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

Documents

1 file
  • 4
    ownership.xmlPrimary